Restoration of Trading

RNS Number : 0411J

Futura Medical PLC

27 November 2008

 



For immediate release

27 November 2008

Futura Medical plc

('Futura' or 'the Group' or 'the Company')

Restoration of trading on AIM

Futura Medical plc (AIM: FUM) announces that trading in Futura's shares on AIM will be restored with immediate effect following this morning's announcement of a positive regulatory opinion on CSD500, the Company's innovative condom.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.co.uk
Canaccord Adams
Ryan Gaffney / Adria Da Breo Richards	Tel: [phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk

 

END

 

 

MSCBFBBTMMBTTRP